sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
26-Feb-2015 18:03
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 962.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 13-Jan-2015
AIDS Research and Human Retroviruses
Progress toward an HIV cure highlighted in special issue of AIDS Research and Human Retroviruses
A cure for HIV/AIDS is the ultimate goal of rapidly advancing research involving diverse and innovative approaches. A comprehensive collection of articles describing the broad scope and current status of this global effort is published in a special issue of AIDS Research and Human Retroviruses.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 13-Jan-2015
Technology
Fast sorting of CD4+ T cells from whole blood using glass microbubbles
This report demonstrated a new cell sorting technology for isolating CD4 positive T cells which may be used for HIV disease monitoring in resource-limited areas such as the developing countries in Africa.

Contact: Philly Lim
mllim@wspc.com.sg
65-646-65775
World Scientific

Public Release: 12-Jan-2015
Bioinformatics
Software created to help find a cure for a 'great neglected disease'
For decades, scientists around the world have worked to develop a treatment for schistosomiasis, a debilitating water-born parasite. To aid this research, scientists at San Francisco State University have developed software that helps assess the impact of a drug on the parasite. Singh and his team recently completed the Quantal Dose Response Calculator, software that analyzes images showing the effects of potential drugs on parasites and quantifies their effectiveness.

Contact: Beth Tagawa
btagawa@sfsu.edu
415-338-6745
San Francisco State University

Public Release: 12-Jan-2015
Proceedings of the National Academy of Sciences
Hybrid 'super mosquito' resistant to insecticide-treated bed nets
A hybrid mosquito, resulting from interbreeding of two malaria mosquitoes, now has the ability to survive the insecticides used to treat bed nets -- which have been key to preventing the spread of malaria in humans.
National Institutes of Health

Contact: Patricia Bailey
pjbailey@ucdavis.edu
530-752-9843
University of California - Davis

Public Release: 8-Jan-2015
The Lancet Infectious Diseases
Study links birth control shot to moderately increased risk of HIV infection
An analysis of 12 observational studies from sub-Saharan Africa involving 39,560 women has found that use of an injectable birth control moderately increased the risk of becoming infected with HIV. The risk increased by 40 percent compared with women using other contraceptive methods or no birth control.

Contact: Sarah Yang
scyang@berkeley.edu
510-643-7741
University of California - Berkeley

Public Release: 8-Jan-2015
Science
Treatment for parasitic worms helps animals survive infectious diseases -- and spread them
In a new study of African buffalo, University of Georgia ecologist Vanessa Ezenwa has found that de-worming drastically improves an animal's chances of surviving bovine tuberculosis -- but with the consequence of increasing the spread of TB in the population.
National Science Foundation

Contact: Cheryl Dybas
cdybas@nsf.gov
703-292-7734
National Science Foundation

Public Release: 8-Jan-2015
PLOS Pathogens
Study links common human protein to adverse parasitic worm infections
Worm infections represent a major global public health problem, leading to a variety of debilitating diseases and conditions. Scientists at the University of California, Riverside and colleagues have made a discovery that could lead to more effective diagnostic and treatment strategies for worm infections and their symptoms. The researchers found that resistin, an immune protein commonly found in human serum, instigates an inappropriate inflammatory response to worm infections, impairing the clearance of the worm.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Kathy Barton
kathryn.barton@ucr.edu
951-827-4598
University of California - Riverside

Public Release: 8-Jan-2015
WHO grants approval for safe, effective meningitis A vaccine for infants
The World Health Organization has opened the door to routine immunization of infants in sub-Saharan Africa by approving for use an innovative and affordable vaccine that has all but rid the meningitis belt of a major cause of deadly epidemics.

Contact: Katy Lenard
klenard@burnesscommunications.com
301-280-5719
Burness Communications

Public Release: 8-Jan-2015
Science
Deworming programs in animal, human populations may have unwanted impacts
A study of the effects of worming medications on infectious disease in wildlife herds showed an unexpected and alarming result -- it helped reduce individual deaths from a bovine tuberculosis infection, but hugely increased the potential for spread of the disease to other animals. The findings suggest that some treatments may increase problems with diseases they were meant to reduce.
National Science Foundation

Contact: Anna Jolles
jollesa@science.oregonstate.edu
541-737-4719
Oregon State University

Public Release: 6-Jan-2015
Journal of Infectious Diseases
Ben-Gurion University researchers discover that AAT drug may prevent deadly infections
In the study, mice were directly infected with highly lethal live bacteria, sepsis and peritonitis. The initial aim was to exclude the possibility that AAT, might worsen infections in patients who are being treated with the drug. AAT is currently being used to treat new clinical indications like type 1 diabetes, emphysema and graft versus host disease. Instead, the BGU research group unexpectedly discovered that the treated mice combatted these lethal infections better than the untreated mice.

Contact: Andrew Lavin
andrewlavin@alavin.com
516-353-2505
American Associates, Ben-Gurion University of the Negev

Public Release: 6-Jan-2015
Lancet Infectious Diseases
Pneumonia risk far higher for HIV-positive children, study shows
HIV-positive children in developing countries are six times more likely to die from pneumonia than children without the virus, research from the University of Edinburgh suggests.
World Health Organisation

Contact: Andrew Moffat
andrew.moffat@ed.ac.uk
44-131-650-9836
University of Edinburgh

Public Release: 5-Jan-2015
Proceedings of the National Academy of Sciences
Whole plant therapy shows promise to beat malaria parasites' drug resistance
For decades, physicians and public health officials worldwide have been thwarted by the malaria parasite's ability to evolve resistance to the succession of drugs developed to treat it. But now University of Massachusetts Amherst microbiologist Stephen Rich and his research team report an effective and sustainable malaria intervention that shows great promise in laboratory models.
UMass Center for Clinical and Translational Science, Worcester Polytechnic Institute

Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 1-Jan-2015
Science
Killing for DNA: A predatory device in the cholera bacterium
Publishing in Science, EPFL scientists have uncovered the unconventional way that the cholera bacterium stabs and kills other bacteria to steal their DNA, making it potentially more virulent.
Swiss National Science Foundation, European Research Council

Contact: Nik Papageorgiou
n.papageorgiou@epfl.ch
41-216-932-105
Ecole Polytechnique Fédérale de Lausanne

Public Release: 30-Dec-2014
Speeding up Ebola drug production
Researchers at the University of California, Davis will explore ways to speed production of the Ebola drug with a $200,000 rapid-response grant from the National Science Foundation.
National Science Foundation

Contact: Andy Fell
ahfell@ucdavis.edu
530-752-4533
University of California - Davis

Public Release: 30-Dec-2014
PLOS Medicine
Malaria combination drug therapy for children
A drug combination of artemisinin-naphthoquine should be considered for the treatment of children with uncomplicated malaria in settings where multiple parasite species cause malaria according to Tim Davis from University of Western Australia, Fremantle, Australia and colleagues in new research published in this week's PLOS Medicine.
National Health and Medical Research Council

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 29-Dec-2014
Annals of Internal Medicine
Annals of Internal Medicine tip sheet for Dec. 30, 2014
Editorials being published in the next issue of Annals of Internal Medicine include 'Medical ethicists offer recommendations for delivering life-sustaining therapies to Ebola patients' and 'Former Surgeon General discusses credibility and influence of 'The Nation's Doctor'.'

Contact: Megan Hanks
mhanks@acponline.org
215-351-2656
American College of Physicians

Public Release: 23-Dec-2014
Grant supports use of data science to optimize HIV treatment monitoring
A Brown University biostatistician and an infectious disease specialist have received a $3.5-million grant to develop new ways to use data from patient health records to optimize effectiveness of HIV treatment where resources are limited, such as in the developing world. They will work with an HIV care program in Kenya that provides healthcare to more than 130,000 patients a year.
National Institutes of Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 23-Dec-2014
The Lancet
Scientists report on trial of early-generation Ebola, Marburg vaccine candidates
esults of an early-stage clinical trial of two experimental vaccines against Ebola and Marburg viruses -- the first to be completed in an African country -- showed that they were safe and induced immune responses in healthy Ugandan adult volunteers.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 23-Dec-2014
JAMA
Maternal supplementation with multiple micronutrients compared with iron-folic acid
In Bangladesh, daily maternal supplementation of multiple micronutrients compared to iron-folic acid before and after childbirth did not reduce all-cause infant mortality to age 6 months, but did result in significant reductions in preterm birth and low birth weight, according to a study in the Dec. 24/31 issue of JAMA.

Contact: Stephanie Desmon
Sdesmon1@jhu.edu
The JAMA Network Journals

Public Release: 22-Dec-2014
Proceedings of the National Academy of Sciences
Study: Extra income boosts health of elderly in poor countries
Boosting the incomes of poor, elderly residents in developing countries can significantly improve their health and well-being, particularly in lung function and memory, a new study shows.
State of Yucatan, NIH/National Institute on Aging, RAND Corporation

Contact: Merrill Balassone
balasson@usc.edu
213-740-6156
University of Southern California

Public Release: 21-Dec-2014
Lancet Global Health
IMF lending undermined healthcare provision in Ebola-stricken West Africa
Researchers criticize reforms advocated by the IMF for chronically under-funded and insufficiently staffed health systems in Guinea, Liberia and Sierra Leone. They say these policies contributed to 'lack of preparedness' of West African health systems to cope with disease and emergencies such as Ebola.

Contact: Alexander Kentikelenis
aek37@cam.ac.uk
44-759-321-2319
University of Cambridge

Public Release: 18-Dec-2014
Journal of Clinical Endocrinology and Metabolism
Urban stressors may contribute to rising rate of diabetes in developing nations
As people in developing nations relocate from rural areas to cities, the increased stress is affecting their hormone levels and making them more susceptible to diabetes and other metabolic disorders, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Contact: Jenni Glenn Gingery
jgingery@endocrine.org
202-971-3655
The Endocrine Society

Public Release: 18-Dec-2014
PLOS Genetics
Fast-changing genes help malaria to hide in the human body
A new study, which shows how malaria parasites behave when they live in human red blood cells, could explain why the deadly infection has proved so hard to beat. Scientists have found that Plasmodium falciparum parasites can rapidly change the proteins on the surface of their host cells in order to hide from the immune system. Around a million new and unrecognizable surface proteins can be created in every infected human every two days.
Wellcome Trust, Medical Research Council

Contact: Mary Clarke
press.office@sanger.ac.uk
44-122-349-2368
Wellcome Trust Sanger Institute

Public Release: 17-Dec-2014
The Lancet
Life expectancy increases globally as death toll falls from major diseases
People are living much longer worldwide than they were two decades ago, as death rates from infectious diseases and cardiovascular disease have fallen, according to a new, first-ever journal publication of country-specific cause-of-death data for 188 countries.

Contact: Rhonda Stewart
stewartr@uw.edu
206-897-2863
Institute for Health Metrics and Evaluation

Public Release: 16-Dec-2014
Neglected disease research in Lao PDR -- capacity building in Burundi
This year, the R. Geigy Foundation in Basel, Switzerland, confers two awards: one to the Laotian scientist Somphou Sayasone, the other to the Swiss TPH Jubilee Project 'Connecting the Dots.' The value of the prizes awarded is 10,000 CHF and 70,000 CHF, respectively. With its awards the RGS recognizes excellent achievements in neglected disease research in South-East Asia and capacity building in Burundi.

Contact: Christian Heuss
christian.heuss@unibas.ch
41-612-848-683
Swiss Tropical and Public Health Institute

Showing releases 76-100 out of 962.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>